Rodriguez Brittany, Prinzi Andrea M, Hill Brandon K, Tibbetts Robert, Salazar Heinz, McAdams David, Rivera-Acosta Awilda M, Wungwattana Minkey, Niles Denver T, Silbert Suzane
Department of Pharmacy Services, Texas Children's Hospital, Houston, TX, USA.
US Medical Affairs, bioMérieux, Salt Lake City, UT, USA.
Antimicrob Steward Healthc Epidemiol. 2025 Jul 11;5(1):e149. doi: 10.1017/ash.2025.10039. eCollection 2025.
Antimicrobial resistance (AMR) poses a significant global health threat, projected to cause 10 million deaths annually by 2050. Addressing AMR requires a coordinated, multidisciplinary approach encompassing infectious disease (ID) clinicians, pharmacists, microbiologists, infection preventionists, and policymakers. The inaugural AMR Summit, hosted by bioMérieux in collaboration with Tampa General Hospital and the University of South Florida Morsani College of Medicine in November 2024, convened experts from various fields to explore innovative strategies for combating AMR. Key topics discussed included the role of multidisciplinary teams in antimicrobial stewardship programs, advancements in rapid diagnostic tests and antimicrobial susceptibility testing, the application of implementation science in AMR, and the integration of next-generation sequencing in ID diagnostics. The summit underscored the importance of diagnostic innovation, interdisciplinary collaboration, policy, advocacy, and public engagement in advancing efforts against AMR.
抗菌药物耐药性（AMR）对全球健康构成重大威胁，预计到2050年每年将导致1000万人死亡。应对AMR需要采取协调一致的多学科方法，涵盖传染病（ID）临床医生、药剂师、微生物学家、感染预防专家和政策制定者。2024年11月，由生物梅里埃公司与坦帕综合医院和南佛罗里达大学莫尔萨尼医学院合作主办的首届AMR峰会召集了来自各个领域的专家，探讨对抗AMR的创新策略。讨论的关键主题包括多学科团队在抗菌药物管理计划中的作用、快速诊断测试和抗菌药物敏感性测试的进展、实施科学在AMR中的应用以及下一代测序在ID诊断中的整合。峰会强调了诊断创新、跨学科合作、政策、宣传和公众参与在推进AMR防治工作中的重要性。
